The company will spotlight the breast cancer risk stratification software Volpara Risk Pathways and a new mammography training collaboration with Mammography Educators.
Recognizing the shift from age-based breast cancer screening to screening programs that are more focused on risk stratification, Volpara will be spotlighting its Volpara Risk Pathways™ software at the annual Society of Breast Imaging (SBI)/American College of Radiology (ACR) conference in Savannah, Ga. this week.
Drawing upon patient data from mammography reporting systems or electronic health records, Volpara Risk Pathways reportedly facilitates the identification and management of patients who are at high risk for breast cancer, according to Volpara. The company said the software’s assessment of an individual’s risk for breast cancer enables enhanced triage decisions for supplemental imaging and/or genetic testing.
Volpara will also spotlight the Analytics in Action program, which offers on-site training from Mammography Educators.
“The Analytics in Action program is designed to help deliver high-quality, personalized breast cancer screening by improving image quality, reducing errors, and increasing proficiency and efficiency. We are excited for our partnership with Volpara to deliver hands-on, personalized training sessions designed not only to help address common positioning performance issues but also to create a culture of quality and continuous improvement that ultimately will result in better screening and better patient care,” noted Louise Miller, R.T. (R)(M)(ARRT), CRT, FSBI, FNCBC, the director of education and co-founder of Mammography Educators.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.